Combined treatment with ipratropium bromide and beta-2-adrenoceptor agonists in childhood asthma.

Author: BrattebyL E, FoucardT, LönnerholmG

Paper Details 
Original Abstract of the Article :
The effect of adding ipratropium bromide to treatment with beta-2-adrenoceptor agonists was studied in 13 asthmatic children in a double-blind cross-over trial. In the acute phase of the study inhalation of salbutamol 0.1 mg/kg followed by inhalation of 0.25 mg of ipratropium bromide was found to im...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/2874047

データ提供:米国国立医学図書館(NLM)

Ipratropium Bromide: A Potential Ally in Childhood Asthma Treatment

Asthma, a chronic respiratory condition, can significantly impact the lives of children. This research, like a team of scientists exploring the vast desert of pediatric medicine, investigates the potential of ipratropium bromide, a medication commonly used for asthma, in the treatment of childhood asthma.

A Potential Oasis in the Desert of Asthma

The authors, like skilled guides navigating the complexities of asthma treatment, have found that ipratropium bromide, when combined with other medications, can improve lung function and provide relief from asthma symptoms in children. The study, like a well-marked trail through the desert, highlights the potential of this medication to enhance treatment outcomes and improve the lives of children with asthma.

A New Path to Better Asthma Management

This research, like a beacon of hope in the desert, shines a light on the potential of ipratropium bromide as a valuable tool in the management of childhood asthma. The findings, like a refreshing spring in the desert, offer a potential solution for improving the lives of children with asthma. Further research, like continued exploration through the desert, is needed to fully understand the optimal use of this medication in this population.

Dr.Camel's Conclusion

This research, like a valuable resource in the desert of childhood asthma, provides important insights into the potential of ipratropium bromide to improve treatment outcomes. The study underscores the importance of ongoing research and finding the most effective ways to manage this challenging condition in children.

Date :
  1. Date Completed 1986-09-17
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2874047

DOI: Digital Object Identifier

2874047

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.